december 18 (saturday)

December 18 (Saturday)

Venue Channel 1 Channel 2 Channel 3 Channel 4

09:00

10:30

TSOC Consensus on Pharmacological Treatment for HF

(I) (P.1)

Cross Discipline Session

(I) (P.3)

Pediatric Cardiology (P.5)

TSOC 心臟血管專科訓練認定基準討論會

(P.7)

10:30 11:00 Healthy Break

11:00

12:30

TSOC Consensus on Pharmacological Treatment for HF

(II) (P.2)

Cross Discipline Session

(II) (P.4)

Consensus in TAVR Indication

(P.6)

12:40

14:00

Luncheon Symposium

[AstraZeneca] (P.24)

Luncheon Symposium

[Boehringer-Ingelheim] (P.25)

Luncheon Symposium

[Daiichi Sankyo] (P.26)

Luncheon Symposium

[Bayer] (P.27)

14:00

15:30

TSOC CCS Guidelines: Diagnosis

(I) (P.8)

Update on AF Management &

Therapy (P.10)

Cardiovascular Surgery (P.12)

善用新興工具跨越研究障礙

(P.14)

15:30 16:00

Healthy Break

16:00

17:30

TSOC CCS Guidelines: Management

(II) (P.9)

Advance on Cardiac Pacing (P.11)

Joint Session on Pediatric and CV

Surgery (P.13)

MOST-TSOC Joint Symposium

(P.15)

17:40

19:00

Evening Symposium [Novartis]

(P.28)

Evening Symposium

[Pfizer] (P.29)

Evening Symposium

[Takeda] (P.30)

Evening Symposium

[Novo Nordisk] (P.31)

December 19 (Sunday)

Venue Channel 1 Channel 2 Channel 3 Channel 4

09:00

10:30

Heart Failure (I)

(P.16)

Interventional Cardiology

(I) (P.18)

Cardiac Imaging (I)

(P.20)

Updated Report of the TAIPAN

Registry (P.22)

10:30 11:00

Healthy Break

11:00

12:30

Heart Failure: (II)

(P.17)

Interventional Cardiology

(II) (P.19)

Cardiac Imaging (II)

(P.21)

Hypertension (P.23)

12:40

14:00

Luncheon Symposium

[Pfizer] (P.32)

Luncheon Symposium [Organon]

(P.33)

Luncheon Symposium [Menarini]

(P.34)

Luncheon Symposium

[AstraZeneca] (P.35)

1

12月18日〈星期六〉09:00-10:30 SATURDAY, DECEMBER 18, 2021

Channel 1

TSOC CONSENSUS ON PHARMACOLOGICAL THERAPY FOR

HEART FAILURE (I)

09:00 Opening Remarks ................................................................................ 侯嘉殷

(Charles Jia-Yin Hou)

Chair: 葉宏一(Hung-I Yeh)

09:05 Classification of HF ............................................................................. 吳彥雯

(Yen-Wen Wu)

Chair: 褚柏顯(Pao-Hsien Chu)

09:20 blocker in HFrEF ............................................................................. 林宗憲

(Tsung-Hsien Lin)

Chair: 陳文鍾(Wen-Jone Chen)

09:35 ACEI/ARB in HFrEF ............................................................................. 吳卓鍇

(Cho-Kai Wu)

Chair: 謝宜璋(I-Chang Hsieh)

09:50 MRA in HFrEF ..................................................................................... 林彥宏

(Yen-Hung Lin)

Chair: 趙庭興(Ting-Hsing Chao)

10:05 Ivabradine in HFrEF ............................................................................. 黃金隆

(Jin-Long Huang)

Chair: 林幸榮(Shing-Jong Lin)

10:20 Panel Discussion

10:25 Closing Remarks ................................................................................. 李啟明

(Chii-Ming Lee)

2


Channel 1

TSOC CONSENSUS ON PHARMACOLOGICAL THERAPY FOR

HEART FAILURE (II)

11:00 Opening Remarks ................................................................................ 李啟明

(Chii-Ming Lee)

Chair: 林俊立(Jiunn-Lee Lin)

11:05 Sacubitril/valsartan in HFrEF ................................................................. 翁國昌

(Kwo-Chang Ueng)

Chair: 陳震寰(Chen-Huan Chen)

11:20 SGLT-2 inhibitor in HFrEF ..................................................................... 江晨恩

(Chern-En Chiang)

Chair: 劉秉彥(Ping-Yen Liu)

11:35 Vericiquat in HFrEF .............................................................................. 趙庭興

(Ting-Hsing Chao)

Chair: 王俊傑(Chun-Chieh Wang)

11:50 Expert consensus ................................................................................ 江晨恩

(Chern-En Chiang)

Chair: 李啟明(Chii-Ming Lee)

12:05 Management of HFmrEF and HFpEF ..................................................... 宋思賢

(Shih-Hsien Sung)

Chair: 江晨恩(Chern-En Chiang)


12:25 Closing Remarks ................................................................................. 葉森洲

(San-Jou Yeh)

3


Channel 2

CROSS DISCIPLINE SESSION (I)

CARDIO-ONCOLOGY SECTION

09:00 Opening Remarks ................................................................................ 余文鍾

(Wen-Chung Yu)

Chair: 余文鍾(Wen-Chung Yu)

09:05 Approach to Cardiotoxicity with Immunotherapy for Cancer ...................... 張瑋婷

(Wei-Ting Chang)

Chair: 熊佩韋(Pei-Wei Xiong)

09:30 Focus on Radiation-induced Cardiovascular Disease:

The 2021 TASTRO-TSOC Consensus ................................................... 呂隆昇

(Long-Sheng Lu)

Chair: 楊甯貽(Ning-I Yang)

09:55 ACEI/ARB in HFrEF ............................................................................. 吳卓鍇

(Cho-Kai Wu)

Chair: 楊甯貽(Ning-I Yang)


10:25 Closing Remarks ................................................................................. 楊甯貽

(Ning-I Yang)

4


Channel 2

CROSS DISCIPLINE SESSION (II)

THE CARDIOLOGIST AT THE TIME OF CORONAVIRUS

11:00 Opening Remarks ................................................................................ 吳彥雯

(Yen-Wen Wu)

Chair: 吳彥雯(Yen-Wen Wu)

11:05 Thrombosis & ACS in COVID-19 and Its Relevant Vaccine:

It’s Possible Mechanism- NET ............................................................... 鄭凱鴻

(Kai-Hung Cheng)


11:30 Managing ACS and HF during COVID-19 Pandemic ............................... 王朝永

(Chao-Yung Wang)

Chair: 莊志明(Jimmy Jyh-Ming Juang)

11:55 Virtual Care and Telemedicine ............................................................. 李任光

(Jen-Kuang Lee)

Chair: 莊志明(Jimmy Jyh-Ming Juang)


12:25 Closing Remarks ................................................................................. 莊志明

(Jimmy Jyh-Ming Juang)

5


Channel 3

SYMPOSIUM ON PEDIATRIC CARDIOLOGY

Chairs: 吳美環(Mei-Hwan Wu)、戴任恭(Zen-Kong Dai)

09:00 Epidemiology and Outcomes of Myocarditis in Children ........................... 林明志

(Ming-Chih Lin)

09:15 Diagnosis of Myocarditis in Children ...................................................... 曾偉杰

(Wei-Chieh Tseng)

09:30 Treatment of Pediatric Viral Myocarditis ................................................. 王玠能

(Jieh-Neng Wang)

09:45 An Overviews of mRNA Vaccine Related Myocarditis and

Pericarditis in Adolescents…………. ...................................................... 簡卲如

(Shao-Ju Chien)

10:00 ECG Screening for mRNA Vaccine Related Myocarditis and Pericarditis ... 邱舜南

(Shuenn-Nan Chiu)


6


Channel 3

CONSENSUS IN TAVR INDICATION

11:00 Opening Remarks ................................................................................ 殷偉賢

(Wei-Hsian Yin)

Chair: 高憲立(Hsien-Li Kao)

11:03 Comparison between AHA/ACC and ESC Guideline ............................... 鄭正一

(Cheng-I Cheng)

11:13 Q & A

Chair: 張仁平(Jen-Ping Chang)

11:17 The Threshold of Age ........................................................................... 宋思賢

(Shih-Hsien Sung)

11:27 Q & A

Chair: 陳嬰華(Ying-Hwa Chen)

11:31 Bicuspid Aortic Valve and Associated Aortopathy .................................... 蔡峰鈞

(Feng-Chun Tsai)

11:41 Q & A

Chair: 施俊哲(Chun-Che Shih)

11:45 Severe Aortic Stenosis Combined with Complex CAD ............................. 林茂欣

(Mao-Shin Lin)

11:55 Q & A

Chair: 李文領(Wen-Lieng Lee)

11:59 Concomitant Valvular Disease ............................................................... 柯宏彥

(Hung_Yen Ke)

12:03 Q & A

Chair: 康沛倫(Pei-Leun Kang)

12:13 Alternative Access for TAVR vs SAVR .................................................... 李國楨

(Kuo-Chen Lee)

12:23 Q & A

12:27 Closing Remarks ................................................................................. 謝宜璋

(I-Chang Hsieh)

7


Channel 4

TSOC 心臟血管專科訓練認定基準討論會

09:00 Opening Remarks ................................................................................ 陳震寰

(Chen-Huan Chen)

Session I. 心臟血管內科

Chair: 鄭景仁(Jing-Ren Jeng)

09:08 Presentation ........................................................................................ 何鴻鋆

(Hung-Chin Ho)

09:38 與談人: 林庭光(Tin-Kwang Lin)、吳彥雯(Yen-Wen Wu)

09:58 Q & A

10:08 Break

Session II. 心臟血管外科

Chair: 施俊哲(Chun-Che Shih)

10:16 Presentation ........................................................................................ 林萍章

(Pyng Jing Lin)

10:46 與談人: 張忠毅(Chung-Yi Chang)、蔡宜廷(Yi-Ting Tsai)、

阮俊能(Jun-Neng Roan)

11:06 Q & A

11:16 Break

Session III. 兒童心臟血管科

Chair: 吳美環(Mei-Hwan Wu)

11:24 Presentation ........................................................................................ 徐仲豪

(Jong-Hau Hsu)

11:54 與談人: 王主科(Jou-Kou Wang)、吳俊明(Jing-Ming Wu)、

陳銘仁(Ming-Ren Chen)、吳俊仁(Jiunn-Ren Wu)、

楊明浚(Ming-Chun Yang)、黃建富(Chien-Fu Huang)、

詹聖霖(Sheng-Ling Jan)

12:14 Q & A

12:24 Closing Remarks ................................................................................. 吳懿哲

(Yih-Jer Wu)

8


Channel 1

TSOC CCS GUIDELINES (I) : DIAGNOSIS




14:05 Overview of 2022 Taiwan CCS Guidelines ......................................... 翁國昌

(Kwo-Chang Ueng)

Chair: 簡國龍(Kuo-Liong Chien)

14:20 Assessment Risk/Severity in Patients with Suspected CCS

(CCCC point-based LDL-C Prediction Model) ......................................... 林鴻儒

(Hung-Ju Lin)

Chair: 顏學偉(Hsueh-Wei Yen)

14:35 Screening for Asymptomatic Subjects: When, How, and Why ? ................ 陳志成

(Zhih-Cherng Chen)

Chair: 蔡青峰(Chin-Feng Tsai)

14:50 CCTA vs Stress Diagnostic Modalities

(TET/stress echo/SPECT/CMR/PET): Which One to Choose? ................. 吳彥雯

(Yen-Wen Wu)

Chair: 陳清埤(Ching-Pei Chen)

15:05 Subclinical Subjects with Coronary Stenosis < 50% or high CAC:

How and When to Treat? ...................................................................... 劉尊睿

(Tsun-Jui Liu)

Chairs: 翁國昌(Kwo-Chang Ueng、江晨恩(Chern-En Chiang)


9


Channel 1

TSOC CCS GUIDELINES (II) : MANAGEMENT


16:00 LDL-C Target and Pharmacological Treatment ........................................ 李貽恒

(Yi-Heng Li)

Chair: 林宗憲(Tsung-Hsien Lin)

16:10 Diabetes Management: HbA1c Target and Pharmacological Treatment ..... 江晨恩

(Chern-En Chiang)

Chair: 褚柏顯(Pao-Hsien Chu)

16:20 Anti-thrombotic Drugs ........................................................................... 蘇峻弘

(Chun-Hung Su)

Chair: 黃偉春(Wei-Chun Huang)

16:35 Anti-ischemic Drugs ............................................................................. 郭風裕

(Feng-Yu Kuo)

Chair: 謝宜璋(I-Chang Hsieh)

16:50 Revascularization versus OMT .............................................................. 趙庭興

(Ting-Hsing Chao)

Chair: 殷偉賢(Wei-Hsian Yin)

17:05 PCI: When to Intervene ? ..................................................................... 任勗龍

(Hsu-Lung Jen)

Chairs: 翁國昌(Kwo-Chang Ueng、江晨恩(Chern-En Chiang)


10


Channel 2

UPDATE ON AF MANAGEMENT & THERAPY

14:00 Opening Remarks ................................................................................ 陳適安

(Shih-Ann Chen)

Chair: 林彥璋(Yenn-Jiang Lin)

14:03 Clinical Update for AF Screening ........................................................... 趙子凡

(Tze-Fan Chao)

Chair: 王俊傑(Chun-Chieh Wang)

14:15 Who, When and How to Intervene for Subclinical AF ............................... 沃宏達

(Hung-Ta Wo)

Chair: 郭任遠(Jen-Yuan Kuo)

14:27 The Use of AI for AF Detection .............................................................. 林廷澤

(Ting-Tse Lin)

14:39 Chairs: 柯文欽(Wen-Chin Ko)、曹玄明(Hsuan-Ming Tsao)、

黃靜惠(Ching-Hui Huang)

Panel Discussion

Chair: 林亮宇(Lian-Yu Lin)

14:45 Zero-fluoroscopy Catheter Ablation of AF: A Preliminary Report ............... 莊傑貿

(Chieh-Mao Chuang)

Chair: 林維祥(Wei-Shiang Lin)

14:57 New Developments in AF Ablation: HPSD .............................................. 江承鴻

(Cheng-Hung Chiang)

Chair: 賴文德(Wen-Ter Lai)

15:09 New Technology in AF Ablation: Pulsed Field Ablation ............................ 卓士傑

(Shih-Jie Jhuo)

Chairs: 張盛雄(Sheng-Hsiung Chang)、蔡適吉(Su-Kiat Chua)、

羅力瑋(Li-Wei Lo)


15:27 Closing Remarks ................................................................................. 溫明賢

(Ming-Shien Wen)

11


Channel 2

ADVANCE ON CARDIAC PACING

16:00 Opening Remarks ............................................................................. . 溫明賢

(Ming-Shien Wen)

Chair: 蔡青峰(Chin-Feng Tsai)

16:03 Leadless Pacemakers for AV Synchrony ................................................ 莊曜聰

(Yao-Tsung Chuang)

Chair: 葉冠宏(Kuan-Hung Yeh)

16:15 Update on Subcutaneous ICD ............................................................... 廖若男

(Jo-Nan Liao)

Chair: 張坤正(Kuan-Cheng Chang)

16:27 Update on His Bundle Pacing ................................................................ 吳宏彬

(Hung-Pin Wu)

16:39 Chairs: 劉言彬(Yen-Bin Liu)、蕭相江(Hsiang-Chiang Hsiao)、

鄭成泉(Chen-Chuan Cheng)

Panel Discussion

Chair: 陳勉成(Mien-Cheng Chen)

16:45 Update on Left Bundle Branch Area Pacing ............................................ 陳煌中

(Huang-Chung Chen)

Chair: 謝仁哲(Jen-Che Hsieh)

16:57 New Indications for CRT in Heart Failure ................................................ 林圀宏

(Kuo-Hung Lin)

Chair: 林立人(Li-Jen Lin)

17:09 Gaps between the Guideline of Cardiac Pacing and Clinical Practice ........ 陳儒逸

(Ju-Yi Chen)

Chairs: 陳永隆(Yung-Lung Chen)、葉勇信(Yung-Hsin Yeh)、

謝育整(Yu-Cheng Hsieh)


17:27 Closing Remarks ................................................................................. 陳文鍾

(Wen-Jone Chen)

12


Channel 3

CARDIOVASCULAR SURGERY

以 SYNTAX SCORE 觀點來審視個人對 CAD 治療的經驗

Chair: 蔡建松(Chien-Sung Tsai)

14:00 Cardiovascular Surgery Clinical Outcomes following Heart Team Revascularization

Recommendations in Complex Coronary Artery Disease ....................... 殷偉賢

(Wei-Hsian Yin)

Chair: 張忠毅(Chung-Yi Chang)

14:18 Surgical Challenges of Myocardial Revascularization in Patients with

High SYNTAX Score .............................................................................. 陽厚生

(Hou-Sheng Yang)

Chair: 邱冠明(Kuan-Ming Chiu)

14:36 Early Outcomes With PCI in Complex Patients Unsuited to Surgery…. ... 黃慶昌

(Ching-Chang Huang)

Chair: 陳益祥(Yih-Sharng Chen)

14:54 Operative Strategy for complex patients undergoing CABG. ........................ 王植賢

(Chih-Hsien Wang)

Chairs: 施俊哲(Chun-Che Shih)、阮俊能(Jun-Neng Roan)、

張仁平(Jen-Ping Chang)、陳懷民(Huai-Min Chen)、

鄭伯智(Bor-Chih Cheng)


13


Channel 3

JOINT SESSION ON PEDIATRIC AND CV SURGERY 未來台灣小兒心臟內科及外科的走向

Chairs: 張重義(Chung-I Chang)、王主科(Jou-Kou Wang)

16:00 Training for Pediatric Cardiac Surgeon ................................................... 黃書健

(Shu-Chien Huang)

16:15 年輕醫師如何踏入小兒心臟外科的領域，一個半成品的心路歷程，焦

慮，與期待…………………………………………………………….徐綱宏

(Kang-Hong Hsu)

16:30 南臺灣兒心外科現況與未來 .......................................................... 潘俊彥

(Jun-Yen Pan)

16:45 What Will Pediatric Cardiology Look Like in Taiwan by 2040 ? ............... 陳俊安

(Chun-An Chen)

17:00 A New Vision for the Future of Pediatric

Cardiology in Taiwan — My Opinion .................................................. 詹聖霖

(Sheng-Ling Jan)

17:15 Career Development for Future Pediatric Cardiologists: My Personal View

未來兒童心臟科醫師的生涯發展: 我的個人看法………………王玠能

(Jieh-Neng Wang)

14


Channel 4

SYMPOSIUM ON BASIC SCIENCE

善用新興工具跨越研究障礙

14:00 Opening Remarks ................................................................................ 劉秉彥

(Ping-Yen Liu)

Chair: 蔡佳醍(Chia-Ti Tsai)

14:05 Next Generation Sequencing for Cardiovascular Diseases Research —

成大醫院經驗分享 .......................................................................... 劉嚴文

(Yen-Wen Liu)

Chair: 陳偉踐(Wei-Jan Chen)

14:30 Milliplex Biomaker Detection Assays in Cardiovascular Disease

Research………… ............................................................................... 呂信邦

(Hsin-Bang Leu)

Chair: 徐國基(Kou-Gi Shyu)

14:55 Protein Array: Application of Protein Array

Analysis in Cardiovascular Research .......................................................... 王士維

(Shih-Wei Wang)



15:25 Closing Remarks ................................................................................. 葉宏一

(Hung-I Yeh)

15


Channel 4

MOST*-TSOC JOINT SYMPOSIUM

跨領域研究方法觀摩坊

16:00 Opening Remarks ................................................................................ 蔡佳醍

(Chia-Ti Tsai)

Chair: 高嘉宏(Jia-Horng Kao)

16:05 肝臟疾病研究模式與實例 .............................................................. 楊宏志

(Hung-Chih Yang)

Chair: 蔡佳醍(Chia-Ti Tsai)

16:25 心血管疾病研究模式與實例 .......................................................... 林錦生

(Chin-Sheng Lin)

Chair: 林宙晴(Chou-Ching Lin)

16:45 神經疾病研究模式與實例 .............................................................. 謝松蒼

(Sung-Tsang Hsieh)

Chair: 劉秉彥(Ping-Yen Liu)



(Hung-I Yeh)

*Ministry of Science and Technology

16

12月19日〈星期日〉09:00-10:30 SUNDAY, DECEMBER 19, 2021

Channel 1

SGLT2 INHIBITOR – A MAGIC BULLET WITH MYSTERIOUS

MECHANISM



Chair: 侯嘉殷(Charles Jia-Yin Hou)

09:05 SGLT2 Inhibitors HFpEF Data: From Context to Clinical Pearls .......... Javed Butler

Chairs: 李啟明(Chii-Ming Lee)、王兆弘(Chao-Hung Wang)

09:35 SGLT2i --- An OHA Reversed from Safety

Concern to Favorable CV Outcome……………………. ............................ 洪崇烈

(Chung-Lieh Hung)

10:00 Efficacy and Potential Mechanisms of SGLT2i on Renal Function in

Patients with Heart Failure .................................................................... 徐莞曾

(Wan-Tseng Hsu)


(Chii-Ming Lee)

17

12月19日〈星期日〉11:00-12:30 SUMDAY, DECEMBER 19, 2021

Channel 1

ELECTROPHYSIOLOGY INTERVENTION IN ADVANCED HEART

FAILURE

Chairs: 溫明賢(Ming-Shien Wen)、林亮宇(Lian-Yu Lin)

11:00 Atrial Fibrillation in Advanced HF-- Ablation or Not? ................................. 謝育整

(Yu-Cheng Hsieh)

11:30 Intervention of Life Threating VT in Advanced HF .................................... 林彥璋

(Yenn-Jiang Lin)

12:00 Left Bundle Branch Pacing -- The Panacea for

Ventricular Pacing in HFrEF?...................... ........................................... 王俊傑

(Chun-Chieh Wang)

18

12月19日〈星期日〉09 :00-10 :30 SUNDAY, DECEMBER19, 2021

Channel 2

INTERVENTIONAL CARDIOLOGY – MASTER’S MOST MEMORABLE CASE IN 2021

09:00 Opening Remarks ................................................................................ 王志鴻

(Ji-Hung Wang)

Chair: 陳清埤(Ching-Pei Chen)

09:05 My Most Memorable Case in 2021 ......................................................... 王志鴻

(Ji-Hung Wang)

09:20 Q & A

Chair: 張其任(Chi-Jen Chang)

09:25 My Most Memorable Case in 2021 ......................................................... 吳炯仁

(Chiung-Jen Wu)

09:40 Q & A

Chair: 陳志成(Zhih-Cherng Chen)

09:45 My Most Memorable Case in 2021 ......................................................... 李文領

(Wen-Lieng Lee)

10:00 Q & A

Chair: 曹殿萍(Tien-Ping Tsao)

10:05 My Most Memorable Case in 2021 ......................................................... 高憲立

(Hsien-Li Kao)

10:20 Q & A

10:25 Closing Remarks ................................................................................. 曹殿萍

(Tien-Ping Tsao)

Panelists: 蔡政廷(Cheng-Ting Tsai)、郭風裕(Feng-Yu Kuo)、

盧澤民(Tse-Min Lu)

19


Channel 2

INTERVENTIONAL CARDIOLOGY –

PERIPHERAL INTERVENTION

11:00 Opening Remarks ................................................................................ 黃玄禮

(Hsuan-Li Huang)

Which Revascularization Techniques Should be the

First Choice in Acute Limb Ischemia ?

Chair: 黃玄禮(Hsuan-Li Huang)

11:05 Endovascular Revascularization ............................................................ 許栢超

(Po-Chao Hsu)

11:25 Surgical Revascularization .................................................................... 溫日昇

(Jih-Sheng Wen)

Routine Early Catheter-directed Thrombolysis for Submassive Pulmonary

Embolism

Chair: 徐中和(Chung-Ho Hsu)

11:45 Pros .................................................................................................... 李任光

(Jen-Kuang Lee)

12:05 Cons ................................................................................................... 張獻元

(Hsien-Yuan Chang)

12:25 Closing Remarks ................................................................................. 徐中和

(Chung-Ho Hsu)

20


Channel 3

SYMPOSIUM ON CARDIAC IMAGING

CLINICAL APPLICATION OF STRESS ECHO

Chairs:梁馨月(Hsin-Yueh Liang)、謝培欽(Bill Pei-Chin Hsieh)

09:00 Small Aortic Valvular Area, True AS or Pseudo AS? .............................. 呂岱穎

(Dai-Yin Lu)

09:20 Coronary Artery Disease, only TET or Tl201? ....................................... 陳美綾

(Mei-Ling Chen)

09:40 Poor LV Function, transplantation or repeated revascularization? .......... 張瑋婷

(Wei-Ting Chang)

10:00 Exertional Dyspnea, but Preserved LVEF ............................................. 董承昌

(Cheng-Chang Tung)


21


Channel 3

SYMPOSIUM ON CARDIAC IMAGING

PEARLS AND PITFALLS IN IMAGING COMPLEX VALVULAR

HEART DISEASE

Chairs:余文鍾(Wen-Chung Yu)、林隆君(Jiun-Yi Li)

11:00 Echocardiography in Diagnosis of Valvular Heart Disease of Prosthetic Valves

………………………………………………………………………………………李廣祚

(Kuang-Tso Lee)

11:20 Combined and Multiple-Valve Diseases.................................................. 李慶威

(Ching-Wei Lee)

11:40 Adults with Congenital Heart Disease: Focus on the Right-Sided Valves ... 陳俊安

(Chun-An Chen)

12:00 Isolated Tricuspid Regurgitation ............................................................. 黃冠智

(Kuan-Chih Huang)


22


Channel 4

UPDATED REPORT OF THE TAIPAN REGISTRY

09:00 Opening Remarks ................................................................................ 黃偉春

(Wei-Chun Huang)

Chair: 賀萬靖(Wan-Jing Ho)

09:05 TAIPANS Registry 1 Year Report ........................................................... 劉維新

(Wei-Shin Liu)

Chair: 邱昱偉(Yu-Wei Chiu)

09:20 Age Effect in PAH Patient Care ............................................................. 鄭錦昌

(Chin-Chang Cheng)

Chair: 吳懿哲(Yih-Jer Wu)

09:35 Uric Acid as A Biomarker in Distinct Groups of Pulmonary Hypertension ... 吳書豪

(Shu-Hao Wu)

Chair: 林彥宏(Yen-Hung Lin)

09:50 CTD-PAH in Taiwan .............................................................................. 張捷宇

(Chieh-Yu Chang)

Chair: 朱俊源(Chun-Yuan Chu)

10:05 Renal Function and PH ......................................................................... 賴志泓

(Chih-Hung Lai)

Chair: 許志新(Chih-Hsin Hsu)


10:25 Closing Remarks ................................................................................. 趙庭興

(Ting-Hsing Chao)

23


Channel 4

SYMPOSIUM ON 2021 TSOC/TSH* HYPERTENSION GUIDELINE



Chair: 鄭景仁(Jing-Ren Jeng)

11:05 Definition and Classification of Hypertension .......................................... 江晨恩

(Chern-En Chiang)

Chair: 梁興禮(Hsin-Li Liang)

11:20 Diagnosis including Optimal Method to Measure BP in Patients with AF, Out-of-office

BP (HBPM and ABPM) & Central Aortic Pressure.................................... 鄭浩民

(Hao-Min Cheng)

Chair: 吳文憲(Wen-Shiann Wu)

11:35 Blood Pressure Targets......................................................................... 林宗憲

(Tsung-Hsien Lin)

Chair: 黃靜惠(Ching-Hui Huang)

11:50 Drug Therapy ....................................................................................... 王宗道

(Tzung-Dau Wang)

Chair: 蔡惟全(Wei-Chuan Tsai)


12:25 Closing Remarks ................................................................................. 洪惠風

(Huei-Fong Hung)

* Taiwan Hypertension Society

24


Channel 1

LUNCHEON SYMPOSIUM:

COMPREHENSIVE PROTECTION ACROSS CARDIORENAL

CONTINUUM: TWO FACES OF THE SAME COIN

-THE CROSSTALK BETWEEN CARDIOLOGIST AND

NEPHROLOGIST

(AstraZeneca)

12:40 Opening Remarks ................................................................................ 葉森洲

(San-Jou Yeh)

Chair: 葉森洲(San-Jou Yeh)

12:45 How to Manage Cardio-Renal Interplay ?

From Cardiologist’s Perspective ............................................................ 江晨恩

(Chern-En Chiang)

Chair: 許惠恒(Wayne Huey-Herng Sheu)

13:15 How to Manage Cardio-Renal Interplay ?

From Nephrologist’s Perspective ........................................................... 吳明儒

(Ming-Ju Wu)


13:55 Closing Remarks ................................................................................. 許惠恒

(Wayne Huey-Herng Sheu)

25


Channel 2

LUNCHEON SYMPOSIUM:

BROADEN HEART PROTECTION

(Boehringer-Ingelheim)




12:45 Start from EMPA-REG OUTCOME:

Paradigm Shift in Diabetes Care ............................................................ 林宗憲

(Tsung-Hsien Lin)

Chair: 李啟明(Chii-Ming Lee)

13:15 Rise of EMPEROR: Latest Update from SGLT2i in Heart Failure .............. 王俊傑

(Chun-Chieh Wang)



(Chii-Ming Lee)

26


Channel 3

LUNCHEON SYMPOSIUM:

FROM SPAF TO VTE- ANTITHROMBOTIC THERAPY

OPTIMIZATION

(Daiichi Sankyo)

12:40 Opening Remarks ................................................................................ 詹貴川

(Kuei-Chuan Chan)

Chair: 詹貴川(Kuei-Chuan Chan)

12:45 Optimize NOAC Dosage for SPAF-Deep Dive into 4 NOACs RCT ............ 趙子凡

(Tze-Fan Chao)

Chair: 黃玄禮(Hsuan-Li Huang)

13:15 Optimizing Outcomes in Treatment for Venous Thromboembolism ........... 吳家棟

(Chia-Tung Wu)


13:55 Closing Remarks ................................................................................. 黃玄禮

(Hsuan-Li Huang)

27


Channel 4

LUNCHEON SYMPOSIUM:

EMERGING STRATEGY FOR HFREF TREATMENT:

DATA, GUIDELINES, AND APPLICATIONS

(Bayer)

12:40 Opening Remarks ................................................................................ 趙庭興

(Ting-Hsing Chao)


12:45 The Role of Vericiguat in Patients with Heart Failure:

An Overview of VICTORIA and Case Sharing ......................................... 劉銘恩

(Ming-En Liu)

13:10 Q&A

Chair: 陳文鍾(Wen-Jone Chen)

13:20 Learnings from the Past: Strategies for Stroke Prevention in

Elderly AF Patients ............................................................................... 徐千彝

(Chien-Yi Hsu)

13:45 Q&A

13:55 Closing Remarks ................................................................................. 陳文鍾

(Wen-Jone Chen)

28


Channel 1

EVENING SYMPOSIUM:

HOW DO YOU PROVIDE HIGH QUALITY OF HF MANAGEMENT

AND WHAT CAN YOU DO MORE FOR HF PATIENTS

(Novartis)




17:45 From Theory to Real World: How do you Provide the

High Quality of HF Management? ......................................................... 李貽恒

(Yi-Heng Li)


18:15 From Late Treatment to Early Treatment:

What Can You Do More for HF Patients? .............................................. 張鴻猷

(Hung-Yu Chang)

18:45 Panel Discussion .......................................................................................... All

18:55 Closing Remarks ................................................................................. 趙庭興

(Ting-Hsing Chao)

29


Channel 2

EVENING SYMPOSIUM:

LATEST GUIDELINE IMPLICATION ON AF PATIENTS CARE

(Pfizer)

17:40 Opening Remarks ................................................................................ 朱志生

(Chih-Sheng Chu)

Chair: 朱志生(Chih-Sheng Chu)

17:45 What is New on APHRS AF Guideline? ................................................. 詹益欣

(Yi-Hsin Chan)

Chair: 黃世忠(Shih-Chung Huang)

18:15 Case Discussion: Managing Challenging AF Patients ............................ 李俊偉

(Chun-Wei Lee)


18:55 Closing Remarks ................................................................................. 黃世忠

(Shih-Chung Huang)

30


Channel 3

EVENING SYMPOSIUM:

FABRY DISEASE: SYMPTOMS, DIAGNOSIS, AND TREATMENT

(Takeda)

17:40 Opening Remarks ................................................................................ 余文鍾

(Wen-Chung Yu)

Chair: 余文鍾(Wen-Chung Yu)

17:45 New Insights in Pathophysiology of Cardiac Damage in

Fabry Disease ................................................................................ Ales Linhart

(Czech)

Chair: 黃偉春(Wei-Chun Huang)

18:15 Clinical Case Sharing .......................................................................... 林志展

(Chih-Chan Lin)


18:55 Closing Remarks ................................................................................. 黃偉春

(Wei-Chun Huang)

31


Channel 4

EVENING SYMPOSIUM:

ROLE OF GLP-1RAS IN LOWERING ASCVD RISK IN TYPE 2

DIABETES

(Novo Nordisk)

17:40 Opening Remarks ................................................................................ 吳彥雯

(Yen-Wen Wu)


17:45 Exploring the Latest Evidence of CV Benefits with GLP-1RAs ................ 林柏霖

(Po-Lin Lin)

18:15 GLP-1 RA Benefits Extend Beyond MACE Reduction in T2D

Patients from Taiwan Cohor Study ........................................................ 李任光

(Jen-Kuang Lee)


18:55 Closing Remarks ................................................................................. 吳彥雯

(Yen-Wen Wu)

32


Channel 1

LUNCHEON SYMPOSIUM:

A PROMISING NEW ERA IN THE MANAGEMENT OF ATTR-CM

(Pfizer)

12:40 Opening Remarks ................................................................................ 張坤正

(Kuan-Cheng Chang)

Chair: 張坤正(Kuan-Cheng Chang)

12:45 Achieving Non-invasive Diagnosis of ATTR-CM ...................................... 林志展

(Chih-Chan Lin)

Chair: 陳震寰(Chen-Huan Chen)

13:15 Early Diagnosis and Treatment of ATTR-CM:

Why Is It So Important? ........................................................................ 林彥宏

(Yen-Hung Lin)


13:55 Closing Remarks ................................................................................. 陳震寰

(Chen-Huan Chen)

33


Channel 2

LUNCHEON SYMPOSIUM:

JUMP! INTO A NEW ERA OF LIPID MANAGEMENT

(Organon)

12:40 Opening Remarks ................................................................................ 江晨恩

(Chern-En Chiang)


12:45 Targeting LDL- C!. ................................................................................ 陳宗瀛

(Chung-Yin Chen)

13:35 Discussion

13:55 Closing Remarks ................................................................................. 江晨恩

(Chern-En Chiang)

34


Channel 3

LUNCHEON SYMPOSIUM:

BETA BLOCKER ROLE IN HYPERTENSION TREATMENT

(Menarini)

12:40 Opening Remarks ................................................................................ 葉宏一

(Hung-I Yeh)


12:45 What Can We Do Better for HTN and HTN-HF Patients? ......................... 林宗憲

(Tsung-Hsien Lin)

13:15 Should We Treat Men and Women Differently?

The Relationship Between Gender and Hypertension .................................... TBD

( )



(Hung-I Yeh)

35


Channel 1

LUNCHEON SYMPOSIUM:

SAVE MORE LIVES AND ORGAN PROTECTION:

FROM ACS TO CRS (CARDIORENAL SYNDROME)

(AstraZeneca)

12:40 Opening Remarks ................................................................................ 陳志成

(Zhih-Cherng Chen)

Chair: 陳志成(Zhih-Cherng Chen)

12:45 Short and Long Oral Antiplatelet Therapy in Acute Coronary Syndromes:

State of the Art ..................................................................................... 曹承榮

(Chen-Rong Tsao)

Chair: 李貽恒(Yi-Heng Li)

13:15 The Diabetes-kidney-heart Failure Continuum: One Tablet Fits All ........ 吳彥雯

(Yen-Wen Wu)


13:55 Closing Remarks ................................................................................. 李貽恒

(Yi-Heng Li)

december 18 (saturday)

Documents